PROPEL: Results of the pivotal, multicenter, phase II study of pralatrexate in patients with relapsed or refractory peripheral T-cell lymphoma (PTCL) Meeting Abstract


Authors: O'Connor, O.; Pro, B.; Pinter-Brown, L.; Popplewell, L.; Bartlett, N.; Lechowicz, M.; Savage, K.; Coiffier, B.; Saunders, M.; Horwitz, S.
Abstract Title: PROPEL: Results of the pivotal, multicenter, phase II study of pralatrexate in patients with relapsed or refractory peripheral T-cell lymphoma (PTCL)
Meeting Title: 45th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 27
Issue: 15 Suppl.
Meeting Dates: 2009 May 29-Jun 2
Meeting Location: Orlando, FL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2009-05-20
Start Page: 449s
Language: English
ACCESSION: WOS:000276606605470
PROVIDER: wos
DOI: 10.1200/jco.2009.27.15_suppl.8561
Notes: Meeting Abstract: 8561 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Steven M Horwitz
    645 Horwitz